UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.__)
Filed by the Registrant Filed by a party other than the Registrant
Check the appropriate box:
|
Preliminary Proxy Statement |
|
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
|
Definitive Proxy Statement |
|
|
|
Definitive Additional Materials |
|
|
|
Soliciting Material Pursuant to §240.14a-12 |
Syndax Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)
Payment of Filing Fee (Check the appropriate box):
|
No fee required. |
|
|
|
Fee paid previously with preliminary materials. |
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
